Roundup and Its Link to Cancer

Case Background

Roundup, one of the world’s most widely used weed killers, has been at the center of thousands of lawsuits filed by individuals diagnosed with cancer, most often non-Hodgkin’s lymphoma, after prolonged exposure. The product’s key ingredient, glyphosate, has been classified as “probably carcinogenic to humans” by international health authorities, and several clinical studies have shown a significant increase in cancer risk among regular users.

Evidence uncovered in court documents suggests that Monsanto, the original manufacturer of Roundup, was aware of the potential health risks for decades. Internal communications reveal efforts to influence research, manipulate regulatory reviews, and suppress concerns raised by independent scientists. Rather than issue warnings or investigate the dangers more transparently, the company prioritized profit and public image.

Since the first landmark verdict in 2018, juries across the country have awarded billions of dollars to Roundup cancer victims. Bayer, which acquired Monsanto in the same year, has paid out massive settlements and faces tens of thousands of additional claims. The legal landscape continues to shift in favor of victims, as courts continue to recognize the manufacturer’s negligence.

Who is eligible a lawsuit

You may be eligible to file a Roundup claim if you used the product regularly and were later diagnosed with non-Hodgkin’s lymphoma or a related cancer. This includes farmers, landscapers, gardeners, and even homeowners with consistent exposure. If you had any routine contact with Roundup before your diagnosis, talk to us about whether you qualify.

Case details

The legal momentum behind the Roundup cancer lawsuits continues to build. Juries across the U.S. have awarded billions of dollars to victims, and Bayer/Monsanto has already settled tens of thousands of claims.

With thousands more lawsuits still pending and new plaintiffs coming forward, courts are increasingly siding with those who can show a history of Roundup exposure and a cancer diagnosis.

Do I have a case?

Symptoms of non-Hodgkin’s lymphoma

Roundup exposure has been most strongly linked to non-Hodgkin’s lymphoma, a cancer that can develop slowly and without warning. If you’ve used Roundup and are experiencing any of the following symptoms, it’s crucial that you seek medical attention.

• Swollen lymph nodes
• Persistent fatigue
• Fever or night sweats
• Unexplained weight loss
• Abdominal pain or swelling
• Shortness of breath or coughing

Other Blood Cancers That May Qualify

Most Roundup cases involve non-Hodgkin’s lymphoma, but studies show that other blood cancers may also be linked to long-term exposure. You may still qualify if you’ve been diagnosed with:

• Leukemia – abnormal white blood cell growth affecting the body’s ability to fight infection.
• Multiple Myeloma – a bone marrow cancer that often causes fatigue and bone pain.
• Chronic Lymphocytic Leukemia (CLL) – a slow-growing leukemia similar to non-Hodgkin’s lymphoma.
• Hairy Cell Leukemia – a rare form of leukemia seen in some Roundup-related studies.
• Other Lymphatic or Blood Disorders – cancers that impact the immune system or bone marrow.

Even if your diagnosis isn’t non-Hodgkin’s lymphoma, you may still be eligible to file a Roundup claim. Our team can review your medical history and exposure to help determine if you qualify.

The primary victims of Roundup exposure

The people most at risk from Roundup exposure are those who used the product regularly without protective equipment. This includes farmers, groundskeepers, landscapers, and gardeners.

Homeowners who used Roundup for routine yard work may also qualify, especially if exposure happened over several years.

Children and residents living near treated farmland are another vulnerable group. Traces of glyphosate have been found in soil, water, and even household dust, raising serious concerns about indirect exposure.

If you or someone in your family developed cancer and had any contact with Roundup, you may have a case worth exploring.